false
0000102109
0000102109
2026-11-18
2026-11-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report
(Date of earliest event reported): November 18, 2026
DEFI CAPITAL MARKETS, INC.
(Exact name of
registrant as specified in its charter)
| Maryland |
001-31747 |
52-0898545 |
(State or other jurisdiction of
incorporation
or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
11407
Cronhill Drive, Suite A,
Owings Mills, Maryland
21117
(Address of principal executive offices) (Zip Code)
(410)
363-3000
(Registrant’s telephone
number, including area code)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, $0.01 par value |
|
DCM |
|
NYSE
American |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ¨
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 5.07 | Submission of Matters to a Vote of Security Holders. |
On
November 18, 2026, DeFi Capital Markets, Inc., a Maryland corporation (the “Company”) held its 2026
annual meeting of stockholders (the “Meeting”). As of October 20, 2026, the record date for the Meeting, the Company
had outstanding and entitled to vote 3,028,463 shares of the Company’s common stock, par value
$0.001 per share (the “Common Stock”), which constitutes all
of the outstanding voting capital stock of the Company.
At the Meeting, the stockholders
voted on five proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A filed
with the U.S. Securities and Exchange Commission on October 20, 2026. At the Meeting, stockholders appointed two (2) directors,
and approved proposals 2, 3, 4 and 5, each of which were presented for a vote. The tables below set forth the number of votes cast for
and against or withheld, and the number of abstentions or broker non-votes, for each matter voted upon by the Company’s stockholders.
Proposal
One: The election of two (2) Class I director nominees named by the Company to hold office for a term of three
(3) years until the annual meeting of stockholders to be held in 2029.
| | |
For | | |
Against | | |
Abstain | | |
Broker Non-Votes | |
| Milton C. Ault, III | |
| 1,657,780 | | |
| 57,079 | | |
| 987 | | |
| 434,856 | |
| Ronald A. Seff, M.D. | |
| 1,579,967 | | |
| 135,216 | | |
| 663 | | |
| 434,856 | |
Proposal Two:
The ratification of CBIZ CPAs P.C., as the Company’s independent registered public accounting firm for the fiscal year ending December 31,
2026.
| For | | |
Against | | |
Abstain | | |
Broker Non-Votes | |
| | 2,124,421 | | |
| 3,484 | | |
| 22,797 | | |
| 0 | |
Proposal
Three: The approval of an amendment of the Company’s Articles of Incorporation (the “Articles”)
to authorize 25,000,000 shares of preferred stock and to permit the issuance of those 25,000,000 shares of preferred stock with rights
and preferences to be determined by the Company’s Board of Directors from time to time.
| For | | |
Against | | |
Abstain | | |
Broker Non-Votes | |
| | 1,582,929 | | |
| 130,478 | | |
| 2,439 | | |
| 434,856 | |
Proposal Four:
The approval of an amendment of the Articles to authorize 25,000,000 shares of class B common stock.
| For | | |
Against | | |
Abstain | | |
Broker Non-Votes | |
| | 1,556,699 | | |
| 156,829 | | |
| 2,318 | | |
| 434,856 | |
Proposal
Five: The approval, for purposes of complying with Rule 713(a) of the NYSE American, the issuance by the Company
of additional shares of Common Stock underlying the Company’s convertible notes issued or issuable pursuant to the amended and restated
securities purchase agreement dated October 9, 2026.
| For | | |
Against | | |
Abstain | | |
Broker Non-Votes | |
| | 1,699,286 | | |
| 14,373 | | |
| 2,187 | | |
| 434,856 | |
| Item 9.01 | Financial Statements and Exhibits. |
| Exhibit No. |
|
Description |
| 101 |
|
Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language). |
| |
|
|
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101). |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
DEFI CAPITAL MARKETS, INC. |
| |
|
| Dated: November 18, 2026 |
/s/ Harvey B. Grossblatt |
| |
Harvey B. Grossblatt |
| |
President and Chief Executive Officer |